Valerio Therapeutics Société anonyme Balance Sheet Health
Financial Health criteria checks 3/6
Valerio Therapeutics Société anonyme has a total shareholder equity of €14.8M and total debt of €8.4M, which brings its debt-to-equity ratio to 56.4%. Its total assets and total liabilities are €35.3M and €20.5M respectively.
Key information
56.4%
Debt to equity ratio
€8.35m
Debt
Interest coverage ratio | n/a |
Cash | €6.82m |
Equity | €14.81m |
Total liabilities | €20.47m |
Total assets | €35.27m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C4X's short term assets (€13.0M) exceed its short term liabilities (€11.1M).
Long Term Liabilities: C4X's short term assets (€13.0M) exceed its long term liabilities (€9.3M).
Debt to Equity History and Analysis
Debt Level: C4X's net debt to equity ratio (10.4%) is considered satisfactory.
Reducing Debt: C4X's debt to equity ratio has increased from 15.2% to 56.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: C4X has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: C4X has less than a year of cash runway if free cash flow continues to grow at historical rates of 7.2% each year.